This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SupplyChain Matters highlights two other recent strategic announcements from pharmaceutical and drug makers that significantly increase their U.S. In early March, SupplyChain Matters highlighted an announced $27 billion investment from Eli Lilly, billed by this producer as the largest pharmaceutical manufacturing investment in U.S.
The shortage of workers is causing companies to look at non-traditional sources, including individual with a criminal record. facility at an Indianapolis, Ind., Automation can solve labor issues. As machine learning and AI is ramping up, it will be important that we look at our automation strategy.
Given our latest discussions on the impact of the Trump presidency on the supplychain, Tim Barnes’ excellent article shown below is exceptionally timely! This could significantly change the design of current production supplychains for major industrials and pharmaceutical companies. Here is Tim’s article.
We organize all of the trending information in your field so you don't have to. Join 102,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Indianapolis 
Let's personalize your content